Page last updated: 2024-08-17

adenosine monophosphate and Hemorrhagic Thrombocythemia

adenosine monophosphate has been researched along with Hemorrhagic Thrombocythemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Buono, A; De Blasio, G; Ielasi, A; Loffi, M; Tespili, M1
Kaplan, KL; Lages, BA; Rosove, MH; Weiss, HJ1

Other Studies

2 other study(ies) available for adenosine monophosphate and Hemorrhagic Thrombocythemia

ArticleYear
Intracoronary cangrelor administration-assisted primary percutaneous coronary intervention in a patient with essential thrombocythemia and recurrent ST-segment elevation myocardial infarction.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2020, Volume: 21, Issue:10

    Topics: Adenosine Monophosphate; Adult; Angioplasty, Balloon, Coronary; Coronary Thrombosis; Drug-Eluting Stents; Humans; Hydroxyurea; Infusions, Intravenous; Male; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Recurrence; ST Elevation Myocardial Infarction; Thrombocythemia, Essential; Treatment Outcome

2020
Acquired storage pool deficiency with increased platelet-associated IgG. Report of five cases.
    The American journal of medicine, 1980, Volume: 69, Issue:5

    Topics: Adenosine Monophosphate; Adenosine Triphosphate; beta-Thromboglobulin; Blood Platelets; Calcium; Humans; Hypergammaglobulinemia; Immunoglobulin G; Lupus Erythematosus, Systemic; Platelet Aggregation; Purpura, Thrombocytopenic; Serotonin; Thrombocythemia, Essential

1980